GIC joins consortium investing $570m in biotech firm I-Mab

Uploaded By:  Frances Gagua Submitted By:  Staff Reporter Case Study:  No The consortium was led by Hillhouse Capital Group. Sovereign wealth fund GIC has joined a consortium of institutional investors to invest around $570.5m (US$418m) through a private in I-Mab, a China-headquartered clinic-stage biopharmaceutical company, according to a press release. The consortium, led by Hillhouse Capital Group, also include Avidity Partners, OrbiMed, Octagon Capital Advisors, Invus, Lake Bleu Capital, Perceptive Advisors, Cormorant Asset Management, Sphera Healthcare and Alyeska Investment Group. read more